On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Ilya Pharma AB's own share of each project, not the project's full budget.
- Horizon 2020€4.4M · 2 projects
- Horizon Europe€294k · 1 project
Projects
3 EU-funded projects, newest first. Ilya Pharma AB led 2 of them as coordinator. Each links to the official record.
- B-ACTIVEPartner
Training of young scientists in the Biological regulation of the chemokine network to improve treatment of ACTIVE inflammation
Horizon Europe · 2024–2027 · Project on CORDIS ↗
€294ktheir share - €1.4Mtheir share
- €3.0Mtheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Katholieke Universiteit LeuvenBelgium · 1 shared project
- Kobenhavns UniversitetDenmark · 1 shared project
- Uppsala UniversitetSweden · 1 shared project
- Universitaet GrazAustria · 1 shared project
- Univerzitetni Klinicni Center LjubljanaSlovenia · 1 shared project
- Synklino A/SDenmark · 1 shared project
- Antagonis Biotherapeutics GmbHAustria · 1 shared project
- Bruker France SASFrance · 1 shared project
- Becton Dickinson BeneluxBelgium · 1 shared project
- Activotec LtdUnited Kingdom · 1 shared project
- Bacthera Denmark A/SDenmark · 1 shared project
- Glycodisplay ApSDenmark · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- antibiotics
- diabetes
- drug discovery
- mortality
- obesity
- oncology
- pandemics
- pathology
- pharmaceutical drugs
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.